Mon Sep 23 17:05:08 UTC 2024: ## Cosmos Health Enters UK Market with C-Scrub Antimicrobial Wash, Securing Over $500,000 in Orders

**CHICAGO –** Cosmos Health Inc. (NASDAQ: COSM), a global healthcare group, has announced its entry into the UK market with its C-Scrub antimicrobial wash, securing purchase orders totaling over $500,000. The orders, spanning from July to September 2024, mark a significant step for the company, which is also in talks to secure additional orders for later in the year.

C-Scrub will be distributed across the UK through hospitals, wholesalers, and online platforms such as Amazon, TikTok, and eBay. The company is optimistic about the UK market’s strong demand and expects the high profit margins of C-Scrub to contribute significantly to its profitability.

**Beyond C-Scrub:** Cosmos Health continues to expand its operations, recently securing an exclusive agreement to distribute Virax Biolabs’ mpox virus detection kits in India and the GCC countries. Additionally, the company has initiated the development of a novel treatment for gastrointestinal disorders (CCDL24) and is expanding its presence in Germany and Qatar through distribution partnerships.

**Investor Perspective:** While Cosmos Health has made significant strides, its financial performance remains a concern. The company operates with a substantial debt burden and has struggled to achieve profitability. While recent stock price volatility could be a sign of investor confidence, the company’s low gross profit margin highlights challenges in converting revenue into profit.

Investors are encouraged to consider Cosmos Health’s financial health and stock performance before making any investment decisions. Further analysis and insights can be found at InvestingPro’s dedicated page for COSM: https://www.investing.com/pro/COSM.

Read More